RESUMEN

Methimazole (MeimzH) is an anti-thyroid drug and the first choice for patients with Grave's disease. Two new copper(II) complexes of this drug: [Cu(MeimzH)(2)(NO(3))(2)]*0.5H(2)O and [Cu(MeimzH)(2)(H(2)O)(2)](NO(3))(2)*H(2)O were synthesized and characterized by elemental analysis, dissolution behavior, thermogravimetric analysis and UV-vis, diffuse reflectance, FTIR and EPR spectroscopies. As it is known that copper(II) cation can act as an inhibitor of alkaline phosphatase (ALP), the inhibitory effect of methimazole and its copper(II) complexes on ALP activity has also been investigated.

Asunto(s)

Fosfatasa Alcalina/antagonistas & inhibidores , Antitiroideos/síntesis química , Antitiroideos/metabolismo , Antitiroideos/uso terapéutico , Cobre/química , Enfermedad de Graves/tratamiento farmacológico , Metimazol/síntesis química , Metimazol/metabolismo , Metimazol/uso terapéutico , Animales , Antitiroideos/química , Espectroscopía de Resonancia por Spin del Electrón , Humanos , Metimazol/química , Espectrofotometría Ultravioleta , Espectroscopía Infrarroja por Transformada de Fourier